Rallybio Corp (NASDAQ:RLYB) filed a Form 8-K with the Securities and Exchange Commission on January 29, 2026, disclosing a material event.
Rallybio Corp's stock currently trades at $0.67 with a market capitalization of $31.7M. The Healthcare company's stock moved following the disclosure.